Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transplant Proc ; 50(10): 3895-3899, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30577283

RESUMO

OBJECTIVE: The aim of this work was to investigate the transplantation efficacy of microencapsulated young market pig islets in a diabetic rat model. METHODS: Islets were isolated and purified from young market pigs obtained from a local slaughterhouse. The islets were encapsulated in barium alginate and subjected to a glucose-induced insulin release functional assay in culture. Microencapsulated islets were transplanted into diabetic Sprague-Dawley rats and removed after 30 days for histologic examination. RESULTS: The mean islet equivalent (IEQ) yield per gram of digested tissue was 3,125 ± 617 IEQ/g after isolation and 2,618 ± 917 IEQ/g after purification, respectively. Host rats' blood glucose concentrations normalized (from 22.3 ± 2.7 mmol/L to 5.1 ± 0.67 mmol/L) following encapsulated islet transplantation. After graft removal, hyperglycemia recurred in the rats, indicating that the grafts were responsible for maintaining euglycemia. Histology revealed viable islets in the capsules 30 days after graft removal. Immunolabeling of insulin verified that ß-cells within the capsules remained well granulated. No fibrosis or immune cells were found in histopathology. CONCLUSIONS: Barium alginate encapsulation of young market pig islets can normalize glucose regulation in diabetic rats without fibrosis or an immunologic response.


Assuntos
Diabetes Mellitus Experimental/cirurgia , Composição de Medicamentos/métodos , Transplante das Ilhotas Pancreáticas/métodos , Transplante Heterólogo/métodos , Alginatos , Animais , Diabetes Mellitus Experimental/sangue , Hiperglicemia/etiologia , Ilhotas Pancreáticas/fisiologia , Transplante das Ilhotas Pancreáticas/imunologia , Masculino , Ratos , Ratos Sprague-Dawley , Sus scrofa
2.
AJNR Am J Neuroradiol ; 37(11): 2115-2122, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27365332

RESUMO

BACKGROUND AND PURPOSE: Type 2 diabetes is associated with an increased risk of dementia. This study investigated the global connectivity patterns in the brains of patients with type 2 diabetes by using a functional MR imaging technique. MATERIALS AND METHODS: Forty patients and 43 age-, sex-, and education-matched healthy controls underwent resting-state functional imaging in a 3T MR imaging unit. Degree centrality, a commonly used measurement of global connectivity, was computed for a full-brain exploration of the regions influenced by type 2 diabetes. We then examined the functional connectivity of each region by using the seed-based approach. Finally, voxelwise correlation analyses were performed to explore the relationship among the connectivity changes, cognitive performance, and diabetes-related variables. RESULTS: Patients exhibited decreased degree centrality in the left lingual gyrus and increased centrality in the right insula and dorsal anterior cingulate cortex (corrected P < .05). The occipital network anchored in the lingual gyrus showed extensively reduced connectivity, while the network connectivity of the insula and cingulate cortex (mostly included in the salience network) was significantly elevated (corrected P < .05). Correlational analyses revealed that in the diabetic group, impaired visual memory and executive function performance were correlated with occipital hypoconnectivity, while higher fasting plasma glucose levels and better executive functioning were related to anterior cingulate cortex hyperconnectivity (all corrected P values < .05). Similar effects were not detected in the controls. CONCLUSIONS: This preliminary study shows that network connectivity is altered in patients with type 2 diabetes, which may provide critical insight into the neural substrate of diabetes-related cognitive decline.

3.
Med Vet Entomol ; 29(1): 37-43, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25429906

RESUMO

A new approach employing a combination of pyrethroid and repellent is proposed to improve the protective efficacy of conventional pyrethroid-treated fabrics against mosquito vectors. In this context, the insecticidal and repellent efficacies of commonly used pyrethroids and repellents were evaluated by cone tests and arm-in-cage tests against Stegomyia albopicta (=Aedes albopictus) (Diptera: Culicidae). At concentrations of LD50 (estimated for pyrethroid) or ED50 (estimated for repellent), respectively, the knock-down effects of the pyrethroids or repellents were further compared. The results obtained indicated that deltamethrin and DEET were relatively more effective and thus these were selected for further study. Synergistic interaction was observed between deltamethrin and DEET at the ratios of 5 : 1, 2 : 1, 1 : 1 and 1 : 2 (but not 1 : 5). An optimal mixing ratio of 7 : 5 was then microencapsulated and adhered to fabrics using a fixing agent. Fabrics impregnated by microencapsulated mixtures gained extended washing durability compared with those treated with a conventional dipping method. Results indicated that this approach represents a promising method for the future impregnation of bednet, curtain and combat uniform materials.


Assuntos
Vestuário , Culicidae , Composição de Medicamentos/métodos , Repelentes de Insetos , Inseticidas , Controle de Mosquitos/métodos , Aedes/efeitos dos fármacos , Animais , Cromatografia Líquida de Alta Pressão , Culicidae/efeitos dos fármacos , DEET , Lavanderia , Nitrilas , Permetrina , Piperidinas , Propionatos , Piretrinas
4.
Br J Cancer ; 109(4): 1031-9, 2013 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-23868000

RESUMO

BACKGROUND: The distinct expression pattern of tumour-associated antigens (TAAs) might be a critical reason for the inefficacy of immunity-based treatments and heterogeneous postsurgical recovery in patients with solid tumours, including hepatocellular carcinoma (HCC). However, little is known about the clinical value of the coexpression patterns of multiple TAAs. METHODS: We determined the expression of multiple TAAs with identified immunogenicity (GPC3, AFP, SSX-2, NY-ESO-1, EpCAM, midkine) and the density of tumour-infiltrating immune cells by immunohistochemistry in a panel of 362 primary HCC patients. We evaluated the association between the TAAs, immune cell infiltration, clinicopathological parameters, and prognosis. RESULTS: Patients who coexpressed more TAAs had better prognosis (P<0.00001, overall survival). The integrated pattern of TAA was associated with good differentiation and small tumour size, and with more CD57(+) natural killer and CD20(+) B-cell infiltration (P<0.05). Multivariate Cox proportional hazards analysis identified the TAA index as an independent prognostic indicator (hazard ratio 0.625; 95% confidence interval 0.467-0.837; P=0.002), and could further predict patient prognosis in collaboration with local immune infiltration. CONCLUSION: Our results could provide new evidence for the improvement of prognostic molecular signatures in HCC, and a novel rationale for patient enrolment in future immunotherapeutic trials and/or clinical treatments.


Assuntos
Antígenos de Neoplasias/imunologia , Carcinoma Hepatocelular/imunologia , Neoplasias Hepáticas/imunologia , Adulto , Idoso , Linfócitos B , Carcinoma Hepatocelular/mortalidade , Moléculas de Adesão Celular/imunologia , Contagem de Células , Progressão da Doença , Molécula de Adesão da Célula Epitelial , Feminino , Glipicanas/imunologia , Humanos , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Células Matadoras Naturais , Neoplasias Hepáticas/mortalidade , Linfócitos do Interstício Tumoral/imunologia , Masculino , Proteínas de Membrana/imunologia , Pessoa de Meia-Idade , Midkina , Proteínas de Neoplasias/imunologia , Fatores de Crescimento Neural/imunologia , Prognóstico , Modelos de Riscos Proporcionais , Proteínas Repressoras/imunologia , Adulto Jovem , alfa-Fetoproteínas/imunologia
5.
Mini Rev Med Chem ; 11(12): 1056-74, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21861806

RESUMO

Endophytic fungi are a seemingly inexhaustible source of novel bioactive natural products. Currently, more than 140 fungal metabolites have shown confirmed activity in tumor cell line bioassays. We present the chemical structures of these antitumor metabolites, their corresponding fungal endophytes and host plants, and the activities they exhibited, and briefly discuss some of their action mechanisms. This review emphasizes the role of endophytic fungi as an important source of leads for drug discoveries.


Assuntos
Antineoplásicos/farmacologia , Produtos Biológicos/farmacologia , Fungos/química , Neoplasias/tratamento farmacológico , Antineoplásicos/química , Antineoplásicos/metabolismo , Produtos Biológicos/química , Produtos Biológicos/metabolismo , Proliferação de Células/efeitos dos fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Fungos/metabolismo , Humanos , Neoplasias/patologia , Relação Estrutura-Atividade
6.
Curr Med Chem ; 17(35): 4326-41, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20939811

RESUMO

The phosphoinositide 3-kinase (PI3K)/serine-theronine protein kinase Akt (also known as protein kinase B (PKB))/mammalian target of rapamycin (mTOR) pathway is a vital transduction cascade that is connected with many essential cellular activities, such as growth and survival. Along with extensive pharmacological studies validating the therapeutic potential of targeting the PI3K/Akt/mTOR pathway for the treatment of cancer, kinase inhibitors targeting significant knots of this pathway including PI3K, Akt, mTOR, and 3-phosphoinositide-dependent protein kinase-1 (PDK-1) keep arising and entering clinical studies. Herein, we review the most up-to-date landscape on developing small-molecule kinase inhibitors targeting the PI3K/Akt/mTOR pathway, with emphasis on small-molecule inhibitors which have been progressed into clinical studies.


Assuntos
Antineoplásicos/farmacologia , Neoplasias/tratamento farmacológico , Inibidores de Fosfoinositídeo-3 Quinase , Inibidores de Proteínas Quinases/farmacologia , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Serina-Treonina Quinases TOR/antagonistas & inibidores , Animais , Antineoplásicos/química , Antineoplásicos/metabolismo , Humanos , Estrutura Molecular , Neoplasias/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Inibidores de Proteínas Quinases/química , Inibidores de Proteínas Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Relação Estrutura-Atividade , Serina-Treonina Quinases TOR/metabolismo
7.
Dis Esophagus ; 23(5): 437-43, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20095997

RESUMO

The 5-year survival rate in resectable patients with esophageal cancer is only 20% to 36%. Regional relapse and distant metastasis are responsible for the failure of treatment and the majority of cancer-related deaths. Earlier detection of metastases, especially micrometastases, has the potential for more accurate risk stratification in subsequent therapy decisions. No effective techniques have yet been found to detect metastases in erroneously thought to have early stage disease. This study was designed to investigate the clinical significance of bone marrow micrometastases detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in patients with esophageal cancer. Expression of CK19 mRNA in the bone marrow of 61 patients with esophageal squamous cell carcinoma (ESCC) and 15 benign pulmonary and esophageal disease patients was assessed via RT-PCR. Correlation of CK19 mRNA expression to the clinicopathologic features and prognosis of the 61 patients was analyzed: 21.3% (13/61) were positive for expression of CK19 mRNA in patients with ESCC. No CK19 mRNA was detected of the 15 benign pulmonary and esophageal disease patients. CK19 mRNA expression did not correlate with the clinicopathologic features of the patients with ESCC, but patients with CK19 mRNA-positive bone marrow had earlier recurrence and shorter survival after surgery. In multivariate analysis, CK19 mRNA was found to be an independent predictor of a poor outcome. CK19 mRNA may be used as a molecular maker to detect bone marrow micrometastases in patients with ESCC and may help to select the proper therapy and predict the prognosis.


Assuntos
Biomarcadores Tumorais/metabolismo , Neoplasias da Medula Óssea/metabolismo , Neoplasias da Medula Óssea/secundário , Medula Óssea/metabolismo , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/secundário , Neoplasias Esofágicas/metabolismo , Neoplasias Esofágicas/patologia , Queratina-19/metabolismo , RNA Mensageiro , Adulto , Idoso , Medula Óssea/patologia , Feminino , Humanos , Queratina-19/genética , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Prognóstico , RNA Mensageiro/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa
9.
Phys Rev B Condens Matter ; 49(24): 16942-16952, 1994 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-10010869
13.
14.
Phys Rev B Condens Matter ; 47(23): 15679-15687, 1993 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-10005961
18.
Phys Rev B Condens Matter ; 42(3): 1713-1723, 1990 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-9995602
19.
Phys Rev Lett ; 64(15): 1805-1807, 1990 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-10041493
20.
Phys Rev B Condens Matter ; 38(12): 8142-8153, 1988 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-9945566
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...